Journey Medical Corp
DERM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867066
No open-market purchases or sales by Journey Medical Corp insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $75.2M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Journey Medical Corp as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +3 vs. Q1 2023
- Shares held
- 1.65M
- −40.9K (−2.4%) vs. Q1 2023
- Total value
- $2.63M
- +$7.22K (+0.3%) vs. Q1 2023
- New holders
- 5
- 4 more added
- Sold out
- 2
- 5 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DERM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 71 | $75.2M |
| Q1 2026 | 72 | $55.8M |
| Q4 2025 | 77 | $85.0M |
| Q3 2025 | 68 | $61.9M |
| Q2 2025 | 56 | $46.6M |
| Q1 2025 | 38 | $29.6M |
| Q4 2024 | 37 | $14.8M |
| Q3 2024 | 36 | $12.2M |
| Q2 2024 | 35 | $13.3M |
| Q1 2024 | 33 | $6.68M |
| Q4 2023 | 36 | $7.80M |
| Q3 2023 | 21 | $5.85M |
| Q2 2023 | 20 | $2.63M |
| Q1 2023 | 17 | $2.62M |
| Q4 2022 | 18 | $5.13M |
| Q3 2022 | 20 | $4.62M |
| Q2 2022 | 13 | $6.52M |
| Q1 2022 | 14 | $7.94M |
| Q4 2021 | 14 | $8.76M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Journey Medical Corp; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| B. Riley Financial, Inc. | 753,493 | $1.20M | 0.31% | −21,303−2.7% | Reduced |
| Perkins Capital Management Inc | 226,395 | $360.0K | 0.31% | +8,000+3.7% | Added |
| American Financial Group Inc | 180,000 | $286.0K | 0.09% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 178,706 | $284.1K | 0.03% | −33,651−15.8% | Reduced |
| Neuberger Berman Group LLC | 119,854 | $190.6K | 0.00% | −8,975−7.0% | Reduced |
| First Manhattan Co | 35,294 | $56.1K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 29,494 | $46.9K | 0.00% | 00.0% | Unchanged |
| Brighton Jones LLC | 23,020 | $36.6K | 0.00% | +23,020 | New |
| Vanguard Group Inc | 21,033 | $33.4K | 0.00% | +10.0% | Added |
| National Asset Management, Inc. | 17,250 | $27.4K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 15,001 | $23.9K | 0.00% | +6,273+71.9% | Added |
| Two Sigma Securities, LLC | 12,016 | $19.1K | 0.00% | +12,016 | New |
| Creative Planning | 11,764 | $18.7K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 11,500 | $18.0K | 0.00% | +11,500 | New |
| Allegiance Financial Group Advisory Services LLC | 10,000 | $15.9K | 0.01% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,082 | $6.49K | 0.00% | −1,337−24.7% | Reduced |
| BerganKDV Wealth Management, LLC | 2,000 | $3.18K | 0.00% | +2,000 | New |
| UBS Group AG | 1,875 | $2.98K | 0.00% | −2,323−55.3% | Reduced |
| Wells Fargo & Company | 48 | $76 | 0.00% | +2+4.3% | Added |
| Royal Bank of Canada | 78 | $0 | 0.00% | +78 | New |
| Wealth Alliance Advisory Group, LLC | 0 | $0 | 0.00% | −10,748−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −25,421−100.0% | Sold out |